Search research articles
Contact Us
Filters
Showing results (271-280 of 314) with videos related to
Page
of 32
Sort By:
Nature Communications
|
September 17, 2021
Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
Carla L Alves, Sidse Ehmsen, Mikkel G Terp, et al.
Science Translational Medicine
|
December 17, 2025
Dual PI3K/mTOR inhibition is required to combat resistance to CDK4/6 inhibitor and endocrine therapy in <i>PIK3CA</i>-mutant breast cancer
Carla L Alves, Leena Karimi, Mikkel G Terp, et al.
International Journal of Cancer
|
August 11, 2024
Genomic alterations associated with resistance and circulating tumor DNA dynamics for early detection of progression on CDK4/6 inhibitor in advanced breast cancer
Charlotte K Kindt, Carla L Alves, Sidse Ehmsen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 19, 2015
Acquisition of docetaxel resistance in breast cancer cells reveals upregulation of ABCB1 expression as a key mediator of resistance accompanied by discrete upregulation of other specific genes and pathways
Stine Ninel Hansen, David Westergaard, Mathilde Borg Houlberg Thomsen, et al.
Cancer Research
|
September 10, 2025
SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer
Rikkemaja Isahbell J Møldrup, Mikkel G Terp, Simon T Jakobsen, et al.
Breast Cancer Research : BCR
|
February 19, 2021
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
Kamila Kaminska, Nina Akrap, Johan Staaf, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
July 25, 2013
TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expression
Christina Bjerre, Lena Vinther, Kirstine C Belling, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 9, 2022
Quantitative Phosphoproteomics of the Angiotensin AT<sub>2</sub>-Receptor Signaling Network Identifies HDAC1 (Histone-Deacetylase-1) and p53 as Mediators of Antiproliferation and Apoptosis
A Augusto Peluso, Stefan J Kempf, Thiago Verano-Braga, et al.
Frontiers in Oncology
|
May 9, 2022
Intrinsic Differences in Spatiotemporal Organization and Stromal Cell Interactions Between Isogenic Lung Cancer Cells of Epithelial and Mesenchymal Phenotypes Revealed by High-Dimensional Single-Cell Analysis of Heterotypic 3D Spheroid Models
Maria L Lotsberg, Gro V Røsland, Austin J Rayford, et al.
Clinical and Translational Medicine
|
July 29, 2021
Deleted in malignant brain tumor 1 genetic variation confers urinary tract infection risk in children and mice
David S Hains, Shamik Polley, Dong Liang, et al.
Page
of 32
Search research articles
Search
Showing results (271-280 of 314) with videos related to
Sort By:
Page
of 32
Nature Communications
|
September 17, 2021
Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
Carla L Alves, Sidse Ehmsen, Mikkel G Terp, et al.
Science Translational Medicine
|
December 17, 2025
Dual PI3K/mTOR inhibition is required to combat resistance to CDK4/6 inhibitor and endocrine therapy in <i>PIK3CA</i>-mutant breast cancer
Carla L Alves, Leena Karimi, Mikkel G Terp, et al.
International Journal of Cancer
|
August 11, 2024
Genomic alterations associated with resistance and circulating tumor DNA dynamics for early detection of progression on CDK4/6 inhibitor in advanced breast cancer
Charlotte K Kindt, Carla L Alves, Sidse Ehmsen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
January 19, 2015
Acquisition of docetaxel resistance in breast cancer cells reveals upregulation of ABCB1 expression as a key mediator of resistance accompanied by discrete upregulation of other specific genes and pathways
Stine Ninel Hansen, David Westergaard, Mathilde Borg Houlberg Thomsen, et al.
Cancer Research
|
September 10, 2025
SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer
Rikkemaja Isahbell J Møldrup, Mikkel G Terp, Simon T Jakobsen, et al.
Breast Cancer Research : BCR
|
February 19, 2021
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
Kamila Kaminska, Nina Akrap, Johan Staaf, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
July 25, 2013
TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expression
Christina Bjerre, Lena Vinther, Kirstine C Belling, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 9, 2022
Quantitative Phosphoproteomics of the Angiotensin AT<sub>2</sub>-Receptor Signaling Network Identifies HDAC1 (Histone-Deacetylase-1) and p53 as Mediators of Antiproliferation and Apoptosis
A Augusto Peluso, Stefan J Kempf, Thiago Verano-Braga, et al.
Frontiers in Oncology
|
May 9, 2022
Intrinsic Differences in Spatiotemporal Organization and Stromal Cell Interactions Between Isogenic Lung Cancer Cells of Epithelial and Mesenchymal Phenotypes Revealed by High-Dimensional Single-Cell Analysis of Heterotypic 3D Spheroid Models
Maria L Lotsberg, Gro V Røsland, Austin J Rayford, et al.
Clinical and Translational Medicine
|
July 29, 2021
Deleted in malignant brain tumor 1 genetic variation confers urinary tract infection risk in children and mice
David S Hains, Shamik Polley, Dong Liang, et al.
Page
of 32